14-day Premium Trial Subscription Sign Up For FreeGet Free

Zomedica Pharmaceuticals Corp Stock Forecast NYSE:ZOM

$0.37 (9.64%)

Volume: 21M

Closed: Dec 07, 2021

Hollow Logo Score: -2.724

Zomedica Pharmaceuticals Corp Stock Forecast

$0.37 (9.64%)

Volume: 21M

Closed: Dec 07, 2021

Score Hollow Logo -2.724
Which way will ZOM go? Request
Key Stats
Beta 1.01
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 80 ] RSI14 is 26 and the stock is currently not being overbought or oversold

Big movements in Zomedica Pharmaceuticals Corp stock price on Tuesday moving 14.23% between high and low
(Updated on Dec 07, 2021)


Sell candidate since 2021-11-15 Loss -25.78%

The Zomedica Pharmaceuticals Corp stock price gained 9.64% on the last trading day (Tuesday, 7th Dec 2021), rising from $0.34 to $0.37. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 14.23% from a day low at $0.34 to a day high of $0.39. The price has fallen in 6 of the last 10 days and is down by -14.99% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 21 million shares were bought and sold for approximately $7.71 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.23% during the next 3 months and, with a 90% probability hold a price between $0.26 and $0.43 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 13.06%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zomedica Pharmaceuticals Corp stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.37 and $0.48. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $0.34 and $0.33. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.33 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0488 between high and low, or 14.23%. For the last week, the stock has had a daily average volatility of 10.94%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Zomedica Pharmaceuticals Corp stock A Buy?

Zomedica Pharmaceuticals Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.724

Predicted Opening Price for Zomedica Pharmaceuticals Corp of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$0.37 $0.37 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

HC Wainwright is very positive about ZOM and gave it a "Buy" rating on Nov 16, 2020. The price target was changed from $0.50 to $0.30.

Volatility and Risk
Daily Average Volatility: 10.94 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.94 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $0.40
Price: $0.37
Support: $0.34

ZOM Insider Trading Show all Trades

INSIDER POWER

6.829

Last 100 transactions
Buy: 77 161 355 | Sell: 11 298 651 (Shares)
Date Action Amount Person Type
Nov 18, 2021 Buy 250 000 Powers Johnny D Common Stock, without par value
Oct 01, 2021 Buy 1 000 000 Lock Adrian Stock Option (right to buy)
Oct 01, 2021 Buy 10 000 000 Heaton Larry C Ii Stock Option (right to buy)
Sep 13, 2021 Buy 800 000 Whelan Sean Stock Option (right to buy)
Jun 30, 2021 Buy 543 750 Cohen Robert Common Stock, without par value
Show all Insider Trades
INSIDER POWER

6.829

Last 100 transactions
Buy: 77 161 355 | Sell: 11 298 651 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.42 12.06 %
0.40 7.06 %
0.39 3.98 %
Current price: 0.37
Support 0.35 -6.01 %
0.34 -9.10 %
0.32 -14.10 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.46 23.29 %
0.44 17.64 %
0.40 6.06 %
Current price 0.37
Support 0.34 -8.79%
0.33 -11.55%
0 .

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT